scarlet: brad loncar of loncar investments, thank you.matter if you are bullish or bearish on u.s. big tech, the etf industry has you covered. check out this week's "there is an etf for that." ♪ scarlet: investors who have a view on fang names are spoiled for choice. that is because rex shares, through its micro sectors products, offers exchange traded notes that covered the spectrum of exposure to the nyse fang plus index. there are leverage notes that are long, as well as inversely tied to the 10 companies in the index. you've got the original fang names, facebook, amazon, netflix and alphabet, plus six other well-known tech companies, twitter, apple, alibaba, nvidia, tesla, and baidu. we are focusing on the three times in verse leveraged etf, lso known as fang. as its name implies, fang uses derivatives to achieve three times the opposite of the fang plus index. performance wise, fang trailed the index since launching in january 2018, but be warned that this family of etf's are not buy and hold investments. fang has roughly $25 million

scarlet: brad loncar of loncar investments, thank you. if you are bullish or bearish on u.s. big tech, the etf industry has you covered. check out this week's there is an etf for that. ♪ scarlet: investors who have a view on fang names are spoiled for choice. that is because rex shares through products offers exchange traded notes that covered the spectrum of exposure to the nyse fang index. there are leverage notes that are long, as well is inversely tied to the 10 companies in the index. you've got the original fang names, facebook, amazon, netflix and alphabet, plus six other well-known tech companies, twitter, apple, apple, alibaba, nvidia, tesla, and baidu. we are focusing on the three times in verse leverage etf, also known as fang. fang uses derivatives to achieve three times the opposite of the fang plus index. performance wise, it trailed the index since launching in january 2018, but be warned that this family of etf's are not buy and hold investments. fang has roughly $25 million in assets and is equally weighted with a rebalan

brad loncar is ceo of loncar investments, where they see investment opportunities in chinese biotech.we talk to him, eric balchunas will give us drilldown into loncar's chna funds. eric: you will be hard-pressed to find a more specific etf out there that tracks biotech and pharma in china. here, you have got it is very small, 3 million. if you trade it, use a limit order. the ratio is a little high, but this is highly exotic exposure. look at the holdings. yours truly, i don't recognize any of the companies here. i spoke with analysts and they say it checks out, but this is specific stuff. a lot of biotech and pharma. also, all hong kong listed. let's compare it to chih, the only other health care china etf to get an idea of the difference. you can see here, it is about the same fee and return. look at this, not that many large caps, so you will get more volatility in this one versus the other one. you've got to keep in mind about that. and also the allocation, 30% biotech to 8%. look at the active share to fxi. you literally are not getting any of the stocks in fxi, so the exposure i